Announced on | Meeting on |
Aug 08, 2024 | Aug 14, 2024 |
Quarterly Results & Interim Dividend | |
May 21, 2024 | May 29, 2024 |
Audited Results & Final Dividend | |
Feb 05, 2024 | Feb 13, 2024 |
Quarterly Results & Interim Dividend | |
Nov 03, 2023 | Nov 10, 2023 |
Quarterly Results & Interim Dividend | |
Aug 08, 2023 | Aug 14, 2023 |
Quarterly Results & Interim Dividend |
Panchsheel Organics Share Price
- Open29.00
- High29.00
- Low29.00
- Prev Close0.00
- Volume44
- VWAP(₹)0.00
Panchsheel Org share price insights
Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 6.22% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 474.15% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)Decrease in Cash from Investing
Company has used Rs 7.22 cr for investing activities which is an YoY decrease of 79.0%. (Source: Standalone Financials)Stock Returns vs Nifty Pharma
Stock generated 474.15% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)Panchsheel Org Share Price Update
Panchsheel Organics Ltd. share price remain unchanged from its previous close of Rs 0.00. Panchsheel Organics Ltd. stock last traded price is 29.00
Share Price Value Today/Current/Last 29.00 Previous Day 0.00
Panchsheel Org Share Price Returns
1 Day | 0.0% |
1 Month | N.A. |
3 Months | N.A. |
1 Year | N.A. |
3 Years | N.A. |
5 Years | N.A. |
Key Metrics
PE Ratio(x) | 3.20 |
EPS - TTM(₹) | 9.07 |
MCap(₹ Cr.) | 14.54 |
MCap Rank | 355 |
PB Ratio(x) | N.A. |
Div Yield(%) | 3.45 |
Face Value(₹) | 10.00 |
52W High(₹) | 36.45 |
52W Low(₹) | 19.15 |
MCap/Sales | N.A. |
Beta(1 Month) | N.A. |
BV/Share(₹) | N.A. |
Panchsheel Org Share Recommendations
No Recommendations details available for this stock.
Check out other stock recos.
Panchsheel Org Financials
Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Total Income 26.80 31.40 26.83 24.71 24.73 Total Income Growth (%) -14.66 17.04 8.55 -0.08 -19.43 Total Expenses 22.16 27.10 21.09 19.68 20.14 Total Expenses Growth (%) -18.22 28.48 7.17 -2.28 -23.16 EBIT 4.63 4.30 5.73 5.03 4.59 EBIT Growth (%) 7.74 -25.04 13.95 9.59 2.33 Profit after Tax (PAT) 3.43 2.78 4.26 3.69 3.39 PAT Growth (%) 23.36 -34.74 15.49 8.86 13.41 EBIT Margin (%) 17.28 13.69 21.37 20.36 18.56 Net Profit Margin (%) 12.79 8.85 15.87 14.91 13.69 Basic EPS (₹) 2.60 2.34 3.15 3.02 2.89 All figures in Rs Cr, unless mentioned otherwise
InsightsEmployee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 6.22% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Total Assets 159.05 122.68 73.91 57.86 51.84 Total Assets Growth (%) 29.65 65.99 27.74 11.61 17.42 Total Liabilities 34.02 26.62 26.50 18.18 16.53 Total Liabilities Growth (%) 27.80 0.45 45.76 9.98 20.92 Total Equity 125.03 96.06 47.41 39.68 35.31 Total Equity Growth (%) 30.16 102.62 19.48 12.38 15.81 Current Ratio (x) 3.49 3.22 2.71 2.68 2.62 Total Debt to Equity (x) 0.05 0.06 0.09 0.08 0.12 Contingent Liabilities 0.00 - 2.33 4.44 1.41 All figures in Rs Cr, unless mentioned otherwise
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Net Cash flow from Operating Activities 9.57 0.04 -1.75 5.33 4.69 Net Cash used in Investing Activities -7.22 -34.37 -0.02 -0.59 -2.50 Net Cash flow from Financing Activities 16.03 35.82 -0.60 -1.94 -1.14 Net Cash Flow 18.38 1.49 -2.37 2.80 1.05 Closing Cash & Cash Equivalent 21.85 3.46 1.97 4.34 1.65 Closing Cash & Cash Equivalent Growth (%) 530.61 75.63 -54.55 163.14 174.00 Total Debt/ CFO (x) 0.66 132.53 -2.36 0.62 0.89 All figures in Rs Cr, unless mentioned otherwise
InsightsCash from Operations vs PAT
Operating cash flow of Rs 9.57 cr is 0.68 times compared to the reported net profit of Rs 14.11 cr. (Source: Standalone Financials)Decrease in Cash from Investing
Company has used Rs 7.22 cr for investing activities which is an YoY decrease of 79.0%. (Source: Standalone Financials)
Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 Return on Equity (%) 11.28 14.64 17.62 12.61 14.98 Return on Capital Employed (%) 15.16 19.81 22.71 18.47 20.91 Return on Assets (%) 8.86 11.46 11.30 8.65 10.20 Interest Coverage Ratio (x) 80.01 38.78 44.76 17.93 24.84 Asset Turnover Ratio (x) 0.75 1.05 1.05 85.53 97.40 Price to Earnings (x) 18.25 14.49 18.38 8.51 3.25 Price to Book (x) 2.06 2.12 3.24 1.07 0.49 EV/EBITDA (x) 11.28 9.71 12.03 4.69 2.26 EBITDA Margin (%) 20.33 20.54 18.73 17.85 17.28
Peer Comparison
NAME 1D 1W 1M 3M 1Y 3Y 5Y Kilitch Drug Stock Performance 0.32 2.71 -5.25 -1.82 81.65 104.83 208.45 Zim Laboratories Stock Performance -1.53 -4.53 -2.16 6.11 -13.65 0.00 0.00 Lyka Labs Stock Performance 3.66 -4.10 19.13 39.13 26.46 93.29 830.57 Medicamen Bio Stock Performance -1.39 -2.30 -9.93 -21.75 -41.29 0.00 0.00 Venus Remedies Stock Performance -1.42 1.16 -15.04 16.87 45.19 -26.71 1397.63 All values in %
Stock Returns vs Nifty Smallcap 100
Stock gave a 3 year return of 474.15% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)Stock Returns vs Nifty Pharma
Stock generated 474.15% return as compared to Nifty Pharma which gave investors 64.02% return over 3 year time period. (as of last trading session)
Mutual Funds Ownership
No Data Available
Corporate Actions
Interim Dividend
8%
Aug 23, 2024
Board Meeting
Quarterly Results & Interim Dividend
Aug 08, 2024
Final
8%
May 29, 2024
Announced on Ex-Date Dividend% Aug 23, 2024 Aug 27, 2024 8% Feb 13, 2024 Mar 07, 2024 0% Nov 10, 2023 Dec 04, 2023 8% Aug 14, 2023 Aug 25, 2023 8% May 29, 2024 - 8% Announced on Ex-Date Oct 16, 2021 Dec 06, 2021 Bonus Ratio: 1 share(s) for every 1 shares held No Data Available
No Data Available
Announced on Meeting on Sep 20, 2023 Sep 29, 2023 Rs.0.8000 per share(8%)Final Dividend & A.G.M. Jun 05, 2023 Jul 08, 2023 - Jul 04, 2022 Jul 27, 2022 - May 04, 2022 May 27, 2022 - Aug 12, 2021 - Book closure from Sep 24, 2021 to Sep 30, 2021
About
Panchsheel Organics Ltd., incorporated in the year 1989, is a Small Cap company (having a market cap of Rs 14.54 Crore) operating in Pharmaceuticals sector.
Panchsheel Organics Ltd. key Products/Revenue Segments include Bulk Drugs (Intermediates), Formulations and Other Operating Revenue for the year ending 31-Mar-2023.
For the quarter ended 30-06-2024, the company has reported a Standalone Total Income of Rs 26.80 Crore, down 14.66 % from last quarter Total Income of Rs 31.40 Crore and up 8.34 % from last year same quarter Total Income of Rs 24.73 Crore. Company has reported net profit after tax of Rs 3.43 Crore in latest quarter.
The company’s top management includes Mr.Mahendra A Turakhia, Mr.Kishor A Turakhia, Mrs.Darshana Vishal Shah, Mr.Diwakar Mani Tripathi, Mr.Shambhunath Chakravarti, Mr.Rajesh Ahecchand Turakhia, Mr.Gaurang Natavarbhai Patel, Mr.Hitesh Singh Parihar. Company has Jayesh R Shah & Co as its auditors. As on 30-06-2024, the company has a total of 1.32 Crore shares outstanding.
About Panchsheel Org
Panchsheel Organics Ltd., incorporated in the year 1989, is a Small Cap company (having a market cap of Rs 14.54 Crore) operating in Pharmaceuticals sector. Panchsheel Organics Ltd. key Products/Revenue Segments include Bulk Drugs (Intermediates), Formulations and Other Operating Revenue for the year ending 31-Mar-2023.For the quarter ended 30-06-2024, the company has reported a Standalone Total Income of Rs 26.80 Crore, down 14.66 % from last quarter Total Income of Rs 31.40 Crore and up 8.34 % from last year same quarter Total Income of Rs 24.73 Crore. Company has reported net profit after tax of Rs 3.43 Crore in latest quarter.The company’s top management includes Mr.Mahendra A Turakhia, Mr.Kishor A Turakhia, Mrs.Darshana Vishal Shah, Mr.Diwakar Mani Tripathi, Mr.Shambhunath Chakravarti, Mr.Rajesh Ahecchand Turakhia, Mr.Gaurang Natavarbhai Patel, Mr.Hitesh Singh Parihar. Company has Jayesh R Shah & Co as its auditors. As on 30-06-2024, the company has a total of 1.32 Crore shares outstanding.
Industry
Key Indices Listed On
-
Address
B6 & B7, Sector-C,Industrial Estate,Sanwer Road,Indore, Madhya Pradesh - 452015
Executive Leadership
Mahendra A Turakhia
Chairman & Managing DirectorKishor A Turakhia
Executive DirectorDarshana Vishal Shah
Ind. Non-Executive DirectorDiwakar Mani Tripathi
Ind. Non-Executive DirectorAuditors
Trending in Markets
DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.